The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice

Neurotoxicity Research

Volumn 9, Issue 1, 2006, Pages 59-62

  Kassa, Jirí ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Acute toxicity; Anticholinergic drugs; Mice; Oximes; Tabun

Indexed keywords

ANTIDOTE; CHEMICAL WARFARE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE REACTIVATOR; ORGANOPHOSPHATE; OXIME; TABUN;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG INTERACTION; DRUG SCREENING; LD 50; MALE; MOUSE;

ANIMALS; ANTIDOTES; CHEMICAL WARFARE AGENTS; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE REACTIVATORS; DRUG EVALUATION; DRUG INTERACTIONS; LETHAL DOSE 50; MALE; MICE; OXIMES; PHOSPHORIC ACID ESTERS;

EID: 33645945883     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033308     Document Type: Article

References (13)

1. Bajgar J (2004) Organophosphate/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 38, 151-216.
2. Cabal J, K Kuca and J Kassa (2004) Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol. Toxicol. 95, 81-86.
3. Jokanovic M, M Maksimovic, V Kilibarda, D Jovanovic and D Savic (1996) Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol. Lett. 85, 35-39.
4. Kassa J (2001) The influence of anticholinergic drug selection on the effectiveness of oximes against soman-induced supralethal poisoning in mice. Acta Med. (Hradec Králové 44, 77-79.
5. Kassa J (2002) Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40, 803-816.
6. Kassa J (2004) The influence of the time of antidotal treatment administration on its effectiveness against tabun-induced poisoning in mice. Acta Med. (Hradec Králové 47 (2), 111-114.
7. Katayama S, F Ishizaki, Y Yamamura, T Khoriyama and S Kito (1990) Effects of anticholinergic antiparkinsonic drugs on binding of muscarinic receptor subtypes in rat brain. Res. Commun. Chem. Pathol. Pharmacol. 69, 261-267.
8. Kuca K and J Kassa (2003) A comparison of the ability of a new bispyridinium oxime - 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium) butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzyme Inhib. Med. Chem. 18, 529-535.
9. Kuca K and J Kassa (2004) In vitro reactivation of acetylcholinesterase using the oxime K027. Vet. Hum. Toxicol. 46, 15-18.
10. Kuca K, J Bielavsky, J Cabal and M Bielavska (2003a) Synthesis of a potential reactivator of acetylcholinesterase - 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) - propane dibromide. Tetrahedron Lett. 44, 3123-3125.
11. Kuca K, J Bielavsky, J Cabal and J Kassa (2003b) Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 13, 3545-3547.
12. Nakashima E, J Ishizaki, M Takeda, R Matsushita, K Yokogawa and F Ichimura (1993) Pharmacodynamics of anticholinergic drugs and brain muscarinic receptor alteration in streptozotoxin diabetic rats. Biopharm. Drug Dispos. 14, 673-678.
13. Tallarida R and R Murray (1987) Manual of Pharmacological Calculation with Computer Programs (Springer-Verlag:NEw York), 145.